Angiotensin II attenuates myocardial interstitial acetylcholine release in response to vagal stimulation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 4, 2007, Pages

  Kawada, Toru ^a,b   Yamazaki, Toji ^b   Akiyama, Tsuyoshi ^b   Li, Meihua ^a,c   Zheng, Can ^a,c   Shishido, Toshiaki ^a   Mori, Hidezo ^b   Sugimachi, Masaru ^a  

^a The Center for Advanced Medical Engineering and Informatics   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c Japan Association for the Advancement of Medical Equipment   (Japan)

Author keywords

Cardiac microdialysis; Cats; Losartan

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; LOSARTAN;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN VENTRICLE; CARDIOVASCULAR SYSTEM; CAT; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HEART FUNCTION; HEART RATE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PARASYMPATHETIC GANGLION; PRIORITY JOURNAL; SINUS NODE; VAGUS NERVE STIMULATION;

ACETYLCHOLINE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; CATS; ELECTRIC STIMULATION; GANGLIA, PARASYMPATHETIC; HEART; HEART VENTRICLES; INFUSIONS, INTRAVENOUS; LOSARTAN; MICRODIALYSIS; MYOCARDIUM; RECEPTOR, ANGIOTENSIN, TYPE 1; VAGUS NERVE;

EID: 35348999496     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00424.2007     Document Type: Article

References (30)

1. Akiyama T, Yamazaki T, Ninomiya I. In vivo detection of endogenous acetylcholine release in cat ventricles. Am J Physiol Heart Circ Physiol 266: H854-H860, 1994.
2. 1 receptors. Am J Hypertens 13: 31S-38S, 2000.
3. Andrews PL, Dutia MB, Harris PJ. Angiotensin II does not inhibit vagally-induced bradycardia or gastric contractions in the anaesthetized ferret. Br J Pharmacol 82: 833-837, 1984.
4. 3H]acetylcholine from rat entorhinal cortex in vitro. Brain Res 491: 136-143, 1989.
5. Du XJ, Cox HS, Dart AM, Esler MD. Depression of efferent parasympathetic control of heart rate in rats with myocardial infarction: effect of losartan. J Cardiovasc Pharmacol 31: 937-944, 1998.
6. Edwards C, Doležal V, Tuček S, Zemková H, Vyskočil F. Is an acetylcholine transport system responsible for nonquantal release of acetylcholine at the rodent myoneural junction? Proc Natl Acad Sci USA 82: 3354-3518, 1985.
7. 1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 288: H2271-H2279, 2005.
8. Glantz SA. Primer of Biostatistics (5th ed.). New York: McGraw-Hill, 2002.
9. Hirooka Y, Head GA, Potts PD, Godwin SJ, Bendle RD, Dampney RA. Medullary neurons activated by angiotensin II in the conscious rabbit. Hypertension 27: 287-296, 1996.
10. Hughes J, Roth RH. Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol 41: 239-255, 1971.
11. Johnson TA, Gray AL, Lauenstein JM, Newton SS, Massari VJ. Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles. J Appl Physiol 96: 2265-2272, 2004.
12. Kakinuma Y, Ando M, Kuwabara M, Katare RG, Okudela K, Kobayashi M, Sato T. Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1alpha. FEBS Lett 579: 2111-2118, 2005.
13. Kawada T, Yamazaki T, Akiyama T, Sato T, Shishido T, Inagaki M, Takaki H, Sugimachi M, Sunagawa K. Differential acetylcholine release mechanisms in the ischemic and non-ischemic myocardium. J Mol Cell Cardiol 32: 405-414, 2000.
14. Kawada T, Yamazaki T, Akiyama T, Shishido T, Inagaki M, Uemura K, Miyamoto T, Sugimachi M, Takaki H, Sunagawa K. In vivo assessment of acetylcholine-releasing function at cardiac vagal nerve terminals. Am J Physiol Heart Circ Physiol 281: H139-H145, 2001.
15. 2+ channel antagonists on nerve stimulation-induced and ischemia-induced myocardial interstitial acetylcholine release in cats. Am J Physiol Heart Circ Physiol 291: H2187-H2191, 2006.
16. Konstam MA, Neaton JD, Poole-Wilson PA, Pitt B, Segal R, Sharma D, Dasbach EJ, Carides GW, Dickstein K, Riegger G, Camm AJ, Martinez FA, Bradstreet DC, Ikeda LS, Santoro EP, investigators ELITEII. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II). Am Heart J 150: 123-131, 2005.
17. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D, Howe DM, Kilcoyne L, Metherall J, Benedict C, Yusuf S, Pouleur H, investigators SOLVD. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 86: 431-438, 1992.
18. Lameris TW, de Zeeuw S, Duncker DJ, Alberts G, Boomsma F, Verdouw PD, van den Meiracker AH. Exogenous angiotensin II does not facilitate norepinephrine release in the heart. Hypertension 40: 491-497, 2002.
19. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109: 120-124, 2004.
20. Nakayama Y, Miyano H, Shishido T, Inagaki M, Kawada T, Sugimachi M, Sunagawa K. Heart rate-independent vagal effect on end-systolic elastance of the canine left ventricle under various levels of sympathetic tone. Circulation 104: 2277-2279, 2001.
21. Paul M, Mehr AP, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803, 2006.
22. Peach MJ. Renin-angiotensin system: Biochemistry and mechanisms of action. Physiol Rev 57: 313-370, 1977.
23. Potter EK. Angiotensin inhibits action of vagus nerve at the heart. Br J Pharmacol 75: 9-11, 1982.
24. Qin Q, Downey JM, Cohen MV. Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase. Am J Physiol Heart Circ Physiol 284: H727-H734, 2003.
25. Rechtman M, Majewski H. A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig. Br J Pharmacol 110: 289-296, 1993.
26. Takata Y, Arai T, Suzuki S, Kurihara J, Uezono T, Okubo Y, Kato H. Captopril enhances cardiac vagal but not sympathetic neurotransmission in pithed rats. J Pharmacol Sci 95: 390-393, 2004.
27. Tune JD, Gorman MW, Feigl EO. Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 97: 404-415, 2004.
28. van Kats JP, Danser AH, van Meegen JR, Sassen LM, Verdouw PD, Schalekamp MA. Angiotensin production by the heart. A quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation 98: 73-81, 1998.
29. Yao Z, Gross GJ. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol Heart Circ Physiol 264: H2221-H2225, 1993.
30. 1 receptors. Am J Physiol Heart Circ Physiol 288: H2154-H2162, 2005.